09:58 AM EST - Microbix Biosystems Inc. : Provided an update on the expansion of its quality assessment product lines, announcing the addition of new customers, more products, and steps to expand its production capacity. Microbix’s quality assessment products (QAPs™) are stabilized and inactivated pathogen samples. QAPs are used by proficiency organizations, diagnostic test developers, researchers and clinical laboratories and are now being manufactured under ISO 13485. Microbix has long offered a range of such products to proficiency organizations for use in their clinical laboratory certification programs (its PTDx™ line). Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.25.
